DCU Research Team Meeting 2025

PBC Biomed were delighted to meet with the research team at Dublin City University (DCU) last week to review and refine our collaborative plans for the years ahead.

Our collaboration with DCU remains a key driver in our mission to enhance patient wellness, with their expertise playing a vital role in strengthening the research arm of our development programmes. Together, we are achieving meaningful progress across several of our core technologies, including OsStic, VAPS, ARC, Advanced Metallic Systems, and Additive Manufacturing.

These projects are made possible through the vital support of the Disruptive Technologies Innovation Fund (DTIF), managed by Enterprise Ireland, alongside the contributions from Research Ireland Spoke funding via the I-Form Research Ireland Centre for Advanced Manufacturing and Biodesign Europe. With this strong foundation of collaboration and funding, we are excited to continue pushing the boundaries of medical technology and delivering impactful solutions for patients worldwide.

Pictured from left to right: Nicholas Dunne (DCU), Tanya Levingstone (DCU), Satish Jaiswal (DCU), Tasneem Elafi(DCU), Srishti Agarwal (DCU), Tina Hashemi (DCU), John Redmond, PhD (DCU), Ali Sahebalzamani, PhD (DCU), Gerard Insley, PBC Biomed), Nina Mathastein (PBC Biomed), Emily McNamara (PBC Biomed), and Bronagh O’Doherty O’Doherty (PBC Biomed).

Enterprise Ireland
Disruptive Technologies Innovation Fund
I-Form Research Ireland Centre for Advanced Manufacturing
Dublin City University
DCU Research
DCU Biodesign Europe